Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 23,233 | 10,060 | N/A | N/A |
| Marketable Securities | 63,310 | 2,199 | N/A | N/A |
| TOTAL | $88,007 | $12,444 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 88 | 33 | N/A | N/A |
| Other Non-Current Assets | 1,808 | 339 | 0 | 0 |
| TOTAL | $1,896 | $372 | $N/A | $N/A |
| Total Assets | $89,903 | $12,816 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 6,449 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,452 | 354 | 0 | 0 |
| Accrued Expenses | 2,175 | 3,543 | N/A | N/A |
| TOTAL | $4,847 | $10,346 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 7,435 | N/A | N/A |
| Deferred Revenues | 1,220 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,918 | 751 | 0 | 0 |
| TOTAL | $18,358 | $8,186 | $N/A | $N/A |
| Total Liabilities | $23,205 | $18,532 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | N/A | N/A |
| Retained earnings | -259,675 | -159,801 | N/A | N/A |
| Other shareholders' equity | 326,372 | 154,084 | 0 | 0 |
| TOTAL | $66,698 | $-5,716 | $N/A | $N/A |
| Total Liabilities And Equity | $89,903 | $12,816 | $0 | $0 |